Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1981 Sep;44(3):403–409. doi: 10.1038/bjc.1981.198

Oncofoetal antigens in cancer of the cervix and ovary.

M N Cauchi, S H Koh, D Lim, D L Hay
PMCID: PMC2010760  PMID: 6169360

Abstract

The incidence of oncofoetal antigens has been reported to be increased in patients with gynaecological cancers. In this study the incidence of CEA, AFP, and hCG (beta subunit) were studied in patients with adenocarcinoma of the ovary, adenocarcinoma of the cervix, and squamous-cell carcinoma of the cervix. Using a low cut-off point (CEA 2.5 microgram/l, AFP 5 microgram/l, and hCG 3 i.u./l) there is an unacceptably high proportion of control patients having one or more positive tests (42-54%) compared to cancer-bearing patients (67%). The specificity of the tests can be increased to over 95% by increasing the cut-off point to CEA 10 microgram/l, AFP 10 microgram/l, and hCG 10 i.u./l). Although this reduces the sensitivity considerably, the incidence of false positives in the control population is reduced to nil in non-cancer patients and to 2% in cancer patients tested when free of tumour, compared to 17% of patients with cancer of the ovary, 33% with adenocarcinoma of the cervix, and 6% with squamous-cell carcinoma of the cervix. Patients with adenocarcinoma of the cervix were clearly distinguishable from those with squamous-cell carcinoma of the cervix by these tests. There was also a significant correlation between AFP and hCG levels in adenocarcinoma of the cervix (r = 0.53, P less than 0.05).

Full text

PDF
403

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Carenza L., Gregorio R., Mocci C., Moro M., Pala A. Ectopic human chorionic gonadotropin: gynecological tumors and nonmalignant conditions. Gynecol Oncol. 1980 Aug;10(1):32–38. doi: 10.1016/0090-8258(80)90059-1. [DOI] [PubMed] [Google Scholar]
  2. Cauchi M. N., Goriup D., Riglar C., Quinn M. A., Richardson C. R. Cancer of the endometrium---a multiparametric study. Gynecol Obstet Invest. 1980;11(2):65–74. doi: 10.1159/000299823. [DOI] [PubMed] [Google Scholar]
  3. Coombes R. C., Powles T. J., Gazet J. C., Nash A. G., Ford H. T., McKinna A., Neville A. M. Assessment of biochemical tests to screen for metastases in patients with breast cancer. Lancet. 1980 Feb 9;1(8163):296–297. doi: 10.1016/s0140-6736(80)90790-4. [DOI] [PubMed] [Google Scholar]
  4. DiSaia P. J., Morrow C. P., Haverback B. J., Dyce B. J. Carcinoembryonic antigen in cancer of the female reproductive system. Serial plasma values correlated with disease state. Cancer. 1977 Jun;39(6):2365–2370. doi: 10.1002/1097-0142(197706)39:6<2365::aid-cncr2820390609>3.0.co;2-i. [DOI] [PubMed] [Google Scholar]
  5. Donaldson E. S., van Nagell J. R., Jr, Pursell S., Gay E. C., Meeker W. R., Kashmiri R., van deVoorde J. Multiple biochemical markers in patients with gynecologic malignancies. Cancer. 1980 Mar 1;45(5):948–953. doi: 10.1002/1097-0142(19800301)45:5<948::aid-cncr2820450519>3.0.co;2-q. [DOI] [PubMed] [Google Scholar]
  6. Fishman W. H., Inglis N. R., Vaitukaitis J., Stolbach L. L. Regan isoenzyme and human chorionic gonadotropin in ovarian cancer. Natl Cancer Inst Monogr. 1975 Oct;42:63–73. [PubMed] [Google Scholar]
  7. Franchimont P., Zangerle P. F., Nogarede J., Bury J., Molter F., Reuter A., Hendrick J. C., Collette J. Simultaneous assays of cancer-associated antigens in various neoplastic disorders. Cancer. 1976 Dec;38(6):2287–2295. doi: 10.1002/1097-0142(197612)38:6<2287::aid-cncr2820380616>3.0.co;2-2. [DOI] [PubMed] [Google Scholar]
  8. Hansen H. J., Snyder J. J., Miller E., Vandevoorde J. P., Miller O. N., Hines L. R., Burns J. J. Carcinoembryonic antigen (CEA) assay. A laboratory adjunct in the diagnosis and management of cancer. Hum Pathol. 1974 Mar;5(2):139–147. doi: 10.1016/s0046-8177(74)80061-4. [DOI] [PubMed] [Google Scholar]
  9. Khoo S. K., Daunter B., Mackay E. Carcinoembryonic antigen and beta 2-microglobulin as serum tumor markers in women with genital cancer. Int J Gynaecol Obstet. 1979 Mar-Apr;16(5):388–393. doi: 10.1002/j.1879-3479.1979.tb00471.x. [DOI] [PubMed] [Google Scholar]
  10. Khoo S. K., Whitaker S. V., Jones I. S., Mackay E. V. Carcinoembryonic antigen in patients with residual ovarian cancer. Clinical and pathological correlations. Gynecol Oncol. 1979 Jun;7(3):288–295. doi: 10.1016/0090-8258(79)90106-9. [DOI] [PubMed] [Google Scholar]
  11. Lin C. W., Orcutt M. L., Stolbach L. L. Elevation of histaminase and its concurrence with Regan isoenzyme in ovarian cancer. Cancer Res. 1975 Oct;35(10):2762–2765. [PubMed] [Google Scholar]
  12. Rutanen E. M., Lindgren J., Sipponen P., Stenman U. P., Saksela E., Seppäla M. Carcinoembryonic antigen in malignant and nonmalignant gynecologic tumors: circulating levels and tissue localization. Cancer. 1978 Aug;42(2):581–590. doi: 10.1002/1097-0142(197808)42:2<581::aid-cncr2820420226>3.0.co;2-g. [DOI] [PubMed] [Google Scholar]
  13. Samaan N. A., Smith J. P., Rutledge F. N., Schultz P. N. The significance of measurement of human placental lactogen, human chorionic gonadotropin, and carcinoembryonic antigen in patients with ovarian carcinoma. Am J Obstet Gynecol. 1976 Sep 15;126(2):186–189. doi: 10.1016/0002-9378(76)90273-8. [DOI] [PubMed] [Google Scholar]
  14. Sarjadi S., Daunter B., Mackay E., Magon H., Khoo S. K. A multiparametric approach to tumor markers detectable in serum in patients with carcinoma of the ovary or uterine cervix. Gynecol Oncol. 1980 Oct;10(2):113–124. doi: 10.1016/0090-8258(80)90073-6. [DOI] [PubMed] [Google Scholar]
  15. Seppälä M., Pihko H., Ruoslahti E. Carcinoembryonic antigen and alpha fetoprotein in malignant tumors of the female genital tract. Cancer. 1975 May;35(5):1377–1381. doi: 10.1002/1097-0142(197505)35:5<1377::aid-cncr2820350521>3.0.co;2-q. [DOI] [PubMed] [Google Scholar]
  16. Stone M., Bagshawe K. D., Kardana A., Searle F., Dent J. Beta-human chorionic gonadotrophin and carcino-embryonic antigen in the management of ovarian carcinoma. Br J Obstet Gynaecol. 1977 May;84(5):375–379. doi: 10.1111/j.1471-0528.1977.tb12602.x. [DOI] [PubMed] [Google Scholar]
  17. Vecchio T. J. Predictive value of a single diagnostic test in unselected populations. N Engl J Med. 1966 May 26;274(21):1171–1173. doi: 10.1056/NEJM196605262742104. [DOI] [PubMed] [Google Scholar]
  18. van Nagell J. R., Jr, Meeker W. R., Parker J. C., Jr, Harralson J. D. Carcinoembryonic antigen in patients with gynecologic malignancy. Cancer. 1975 May;35(5):1372–1376. doi: 10.1002/1097-0142(197505)35:5<1372::aid-cncr2820350520>3.0.co;2-7. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES